Cell Genesys (CEGE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gemini who wrote (1090)	1/19/2001 11:17:19 PM
From: scaram(o)uche	Read Replies (1) of 1298

It would have been nice upside. It's an interesting story. A TKTX representative once said that the license wasn't necessary, that it was almost a courtesy of Hoechst to include CEGE. In fact, this individual got visibly agitated, IMO, when asked about the CEGE license at a major meeting. OTOH, CEGE has long referred to TKTX as a "partner". I never bought the TKTX line. The decision itself?...... mixed feelings. I believe that, even if composition of matter is gone, that "degree of purity" claims should stand for those who do the initial biology and build the market. I therefore lean toward Amgen. OTOH, I honestly believe that TKTX circumvented the spirit of Amgen's basic process claims. The verdict is good for biotech. I am pleased. The decision is bad for TKTX, and IMO they definitely have a valid stance. I'm still pleased, as what's good for biotech is ALWAYS going to be my bottom line. Effect on CEGE's business plan? Minimal. Chalk one up for Gordon Binder.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next